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ABSTRACT
Objective: To determine the relative frequencies of gynaecological cancers in Ghana, age and
parity distribution, stage of disease at presentation and the influence of age and parity on
stage at presentation.
Design: Retrospective observational study.
Setting: Korle Bu Teaching Hospital, Accra, Ghana.
Subjects: Cases of gynaecological cancers seen in a fifty two month period.
Results: Cervical cancer was the commonest, constituting about 57.8% of gynaecological
cancers. Ovarian cancer, endometrial cancer, choriocarcinoma and vulval carcinoma
followed in that order. The mean age and parity for cervical carcinoma (52.0[SD12.0] years,
5.8[SD2.7] respectively) were significantly higher than those for ovarian carcinoma
(46.4[SD15.0] years, 3.5[SD3.0] respectively) but not significantly different from those for
endometrial carcinoma (56.0[SD13.5] years, 5.4[SD3.0] respectively). Most patients with
cervical or ovarian carcinoma presented with advanced disease while most with endometrial
carcinoma presented with early stage disease. Age and parity did not have any influence on
the stage at presentation with cervical or ovarian carcinoma. Concerning endometrial
carcinoma, although age did not influence stage at presentation, women of high parity (≥5)
presented with earlier stage disease than those of parity less than 5.
Conclusion: As a first step towards reducing the morbidity and mortality associated with
gynaecological cancers in Ghana, appropriate steps must be taken to reduce the incidence
of cervical carcinoma. In addition, detailed study of the epidemiology of cervical and
endometrial cancers in Ghanaian women is needed to determine whether they share any
other common antecedents in addition to age and parity.
INTRODUCTION
Gynaecological cancers continue to be important
health problems worldwide. The proportion of cancers in
the female which are of genital tract origin range from
31.6% to 35.0% in sub-Saharan Africa, 12.7% to 13.4% in
North America, 13.9% to 16.8% in France and the
Scandinavian countries, 15.5% to 43.1% in South America
and 22.4% to 55.8% in India(1).
One major problem in developing countries, and
especially in sub-Saharan Africa, is the absence of accurate
population and health statistics. It is therefore not possible
to reliably calculate incidence rates for the various cancers.
In such circumstances therefore, reliance has to be placed
on relative frequencies in hospitals as a measure of tumour
incidence.
While in developed countries endometrial carcinoma
is the commonest gynaecological cancer, in African
countries carcinoma of the cervix has been reported in
many series to be the commonest, with most of the patients
presenting in late stages of the disease(1-4).
Age and parity are known to affect the incidence of
gynaecological cancers. Endometrial carcinoma is reported
to be predominantly a disease of ageing, postmenopausal
women, the peak incidence being in the 58-60 years group.
It occurs later in reproductive life than carcinoma of the
cervix which is seen commonly in premenopausal or
perimenopausal women(5). Women of high parity have
relatively low risk of developing endometrial cancer;
pregnancy also protects against ovarian cancer(6). In
sharp contrast, however, multiparity is associated with
increased risk of development of cervical carcinoma(6).
The purpose of this retrospective study, conducted at
the Korle Bu Teaching Hospital, was to determine the
relative frequencies of the various gynaecological cancers,
age and parity distribution, the stage of disease at
presentation and the influence, if any, of age and parity.
Korle Bu Teaching Hospital is the biggest hospital
and the major referral centre in Ghana. It is situated in the
nation’s capital, Accra and serves as the teaching hospital
for the University of Ghana Medical School. Patients with
gynaecological cancer are referred to the Obstetrics and
Gynaecology department of the hospital from all parts of
the country. Until late 1997 there were no facilities for
radiation therapy and women with advanced cancer who
needed radiation therapy had to travel abroad for treatment
if they had the means to do so.
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MATERIALS AND METHODS
The study was originally intended to cover the period from
January 1991 to December 1996. The sources of clinical data
were the ward admission and discharge books and the operating
theatre record books. The data sources for the period July 1993
to February 1995 could not be traced so the actual period covered
was January 1991 to June 1993 and March 1995 to December
1996 (ie a period of 52 months). From these data sources the age,
parity, type of cancer and stage of disease were noted for each
patient admitted with gynaecological cancer. Where the patient
had surgery the above information was confirmed by comparison
with information in the operating theatre record books. Almost
all the patients had had histologically proven gynaecological
carcinoma, though details of histological diagnosis were not
included in this study. Some cases of choriocarcinoma had been
diagnosed on clinical and biochemical grounds.
The data were fed into and analysis performed by personal
computer using Epi-Info version 6. Statistical analysis was
performed using Student “t” test for continuous and Chi square
test for categorical variables; where numbers were small the
Fisher exact two-tailed test was used. Differences were considered
significant if p<0.05.
RESULTS
During the period of study there were 498 women
admitted to the gynaecological unit with gynaecological
cancers. The total number of patients admitted to the unit
during the same period was 17,822. Thus 2.8% of the
admissions were for gynaecological cancers.
Relative frequencies of gynaecological cancers: The
commonest gynaecological cancer was cervical carcinoma,
which constituted almost 58% of the cases(Table 1).
Vaginal cancer and leiomyosarcoma of the body of the
uterus were rare.
Table 1
Relative frequencies of gynaecological cancers









Age distribution (Table 2):  The largest numbers of
gynaecological cancers occurred in the fifth to seventh
decades of life; 70.2% of the cancers occurred in these age
groups. The commonest gynaecological cancers in women
under 30 years of age were ovarian cancer (52.2%) and
choriocarcinoma (41.5%); cervical and endometrial
cancers were rare in this age group and none had vulval or
vaginal carcinoma. The highest mean age was in women
with endometrial cancer while the lowest was in those
with choriocarcinoma; indeed 50% of women with
choriocarcinoma were less than thirty years old. Cervical
carcinoma rose sharply in occurrence from the fourth
decade of life, and remained the commonest cancer in all
age groups from thirty years onwards. The mean age of
women with cervical carcinoma was not significantly
different from that of those who had endometrial carcinoma
(p=0.064), but it was significantly higher than that of
women with ovarian cancer (p<0.001).
Table 2
Age distribution of gynaecological cancers
Age(yrs) No. of patients and type of cancer
Cervix Ovary Endometrium Choriocarcinoma Vulva Vagina Total
<30 1 21 2 17 0 0 41
30-39 39 12 1 10 1 1 64
40-49 81 29 6 7 4 0 127
50-59 83 39 11 0 4 0 137
60-69 51 20 10 0 1 0 82
≥70 31 5 6 0 1 0 43
Not stated 2 - 1 – – – 3
Total 288 126 37 34 11 1 497
Range 26-85 10-74 21-76 16-49 36-70 –
Mean 52.0 46.4 56.0 30.6 49.3 –
(SD) (12.0) (15.0) (13.5) (8.4) (11.1)
The age of the woman with leiomyosarcoma was not stated in the data sources.
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Parity distribution (Table 3): The highest mean parity
was in women with cervical cancer and the lowest in those
with choriocarcinoma. At least 48.6% (18 out of 37) of
women with endometrial cancer were of parity 5 or higher.
There was no significant difference in parity between
women who had cervical and those who had endometrial
carcinomas (p=0.44), but the mean parity for cervical
cancer was significantly higher than that for ovarian
cancer (p<0.001).
Stage at presentation and influence of age and parity
(Table 4): Of the women who had cervical cancer,
87(30.2%) presented with stage IB, 15(5.5%) with stage
IIA and 171(64.3%) with stage IIB or worse disease. In
other words only 35.7% of affected women presented with
a stage of disease that could be treated in Ghana (by radical
surgery) during the period under study. Age and parity did
not seem to influence the stage at presentation (Table 4a).
Table 4
Stage at presentation in relation to age and parity
(a) Cervical cancer
Age (yrs) Stage at presentation p value
IB - IIA IIB - IV
<40 16 24 χ2=0.38
≥40 86 160 p=0.54
Parity
<5 36 53 χ2=1.17
≥5 60 118 p=0.28
b) Ovarian cancer
Age(yrs) Stage at presentation p value
I -II III - IV
<40 6 27 χ2=0.99
≥40 25 68 p=0.32
Parity
<5 19 59 χ2=0.02
≥5 10 29 p=0.88
c) Endometrial carcinoma
Age (yrs) Stage at presentation p value
I-II III-IV
<50 6 3
≥50 21 6 p=0.66*
Parity
<5 7 6
≥5 17 1 p=0.012*
*Fisher two-tailed exact test
With regards to the women with ovarian cancer,
15(11.9%) presented in stage I, 16(12.7%) in stage II,
33(26.2%) in stage III and 62(49.2%) in stage IV. Here
too, age and parity did not influence stage of disease at
presentation (Table 4b).
In the endometrial cancer cases, 27(73%) presented
with stage I, 1(2.7%) with stage II, 2(5.4%) with stage III
and 7(18.9%) with stage IV disease. Although age did not
influence the stage at presentation, women with high
parity (five and above) presented with earlier stage disease
than those with parity less than five (Table 4c).
Those with vulval cancer presented with stage I disease
in 3(27.3%), stage II in 3(27.3%) and stages III and IV in
5(45.5%) cases. The numbers are too small to allow any
reliable conclusions to be drawn as regards the effect of
age or parity on stage of disease at presentation.
DISCUSSION
Gynaecological cancers formed 2.8% of all
gynaecological admissions. This is low compared to 4.18-
4.7% in Nigeria(2,7). The largest numbers, 70.2%, of
gynaecological cancers occurring in the 40-69 year group
is comparable to 72.2% reported from Port Harcourt(2).
Cervical cancer being the commonest gynaecological
cancer is consistent with what has been reported in other
parts of sub-Saharan Africa. The proportion it forms in this
series (57.8%), however, is one of the lowest reported
since within the region the proportion has ranged between
62.8% and 87.3%(1-4,7,8).
Table 3
Parity distribution of gynaecological cancers
Parity No. of patients amd type of cancer
Cervix Ovary Endometrium Choriocarcinoma Vulva Vagina Total
0 3 22 2 9 0 1 37
1-4 86 56 11 16 5 0 174
5-8 128 31 13 6 4 0 182
9+ 50 8 5 1 2 0 66
Not stated 21 9 6 2 0 0 38
Total 288 126 37 34 11 1 497
Mean 5.8 3.5 5.4 2.5 5.4 – –
(SD) (2.7) (3.0) (3.0) (2.7) (3.0)
The woman with leiomyosarcoma had parity of four.
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The position of ovarian cancer as the second
commonest gynaecological cancer is similar to what has
been reported from Zaria, Port Harcourt, (both in Nigeria),
Tanzania and Harare(Zimbabwe). The proportion it forms
in this series, 25.3%, is comparable to the 22.2% and
23.5% in Tanzania and Zaria respectively, though it is
much higher than the 9.6% reported from Harare and the
12.3% from Port Harcourt(2,3,7,8).
In most reports from sub-Saharan Africa
choriocarcinoma is more common than endometrial
carcinoma(2,3,7,8); in this series the latter is slightly more
common. Vulval carcinoma has been the least common, as
shown in this report, while vaginal carcinoma has been
very rare.
The mean age at presentation of 52 years in those with
cervical cancer differs from the much lower mean ages of
between 42 and 47 years reported from other parts of
Africa(3,4,7,8). In spite of this higher mean age, the mean
parity of 5.8 is comparable to the 5-7+ quoted in the above
mentioned reports. It is not too clear why there is this
difference in mean ages. Considering the risk factors for
cervical carcinoma, it is plausible to suggest that Ghanaian
women might start sexual activity at a later age than
women from other parts of Africa; however, the evidence
indicates that there is no difference(9-12).
The higher mean age and parity at presentation of
women with cervical cancer compared to those with
ovarian cancer is consistent with what has been reported
elsewhere(2,3). However, when compared to women who
had endometrial cancer, women with cervical cancer did
not differ significantly with respect to age and parity. This
is very much contrary to the generally accepted view that
women with endometrial cancer are older and of lower
parity than those with cervical cancer. It will be useful to
determine whether in Ghanaian women carcinoma of the
cervix and carcinoma of the endometrium share some
other common epidemiological antecedents.
Many reports have confirmed the situation in the
region in which most women with cervical carcinoma
present with advanced disease. The proportion of women
with early stage disease(IB-IIA) has been as low as 13.3%
in Zaria(Nigeria) and 19% in Zimbabwe; a figure of 34.5%
has been reported from South Africa(7,13,14). It is obvious
that in Korle Bu Teaching Hospital a greater proportion of
women present with early stage disease than in other parts
of Africa. This may be due to patients reporting their
symptoms earlier. However, 35.7% with early stage disease
is too low when compared with developed countries
where most of the patients present with early stage disease.
The absence of any effect of age on stage at presentation
with cervical carcinoma is consistent with some reports
from the region but not with others (14, 15).
It is a recognised phenomenon worldwide that most
women with ovarian cancers present with advanced disease.
This is amply demonstrated in this report in which 75.4%
presented with stage III or IV disease, which is comparable
to 79.5% in Zimbabwe(3).
This series also shows consistency with the general
observation of early stage at presentation with endometrial
carcinoma; 75.7% of patients were in that category.
Considering the high mean parity of women with
endometrial carcinoma and the fact that women of high
parity have significantly higher proportion of early stage
disease than those of low parity, it may be suggested that
in Ghanaian women pregnancy does not so much protect
against endometrial carcinoma as it does against the
development of aggressive forms of the disease.
The mean age for vulval carcinoma, 49.3 years, is
rather low when one considers the fact that even early
invasive carcinoma of the vulva is known to be most
common in the late fifties and early sixties. Indeed, in the
series from Zimbabwe all but one of 31 patients with
vulval carcinoma were older than 55 years(3). It may be
mentioned, however, that a mean age of 43.8 years was
reported from Jamaica about thirty years ago(16) and the
two patients with vulval carcinoma in the Port Harcourt
series were in the 40-49 years group(2).
Choriocarcinoma in Ghana is a disease of relatively
younger women. This is not surprising since, being a
disease associated with pregnancy, it is more likely to
occur in active reproductive life.
In conclusion, cervical carcinoma is the commonest
gynaecological cancer in Ghana, with most patients
presenting with advanced disease. It is obvious that if the
morbidity and mortality associated with gynaecological
cancers are to be reduced then cervical cancers must be the
first to be tackled. Fortunately, cervical cancer is largely
a preventable disease. There is the need to educate the
public on the risk factors, as well as the early symptoms of
the disease, so that people will adopt appropriate behaviour.
More importantly, there is the need to begin to take
concrete steps towards establishing a cervical cancer
screening programme. It is generally acknowledged that
in developing countries, of which Ghana is one, cervical
smear cytology screening is not a viable proposition
considering the economic constraints. However there is
evidence that in lower source settings visual inspection
after acetic acid application may be a reliable method of
screening for precancerous cervical lesions(17). If this is
confirmed in ongoing studies serious consideration must
be given to its adoption in Ghana.
There is also the need for detailed study of the
epidemiology of cervical and endometrial cancers in
Ghanaian women to determine whether they share other
common antecedents in addition to age and parity, since if
these exist, they would have implications for public
education on and the prevention of both cancers.
REFERENCES
1. Cancer incidence in five continents, Volume VII, 1997. Editors:
Parkin D.M., Whelan S.L., Ferlay J., Raymond L., Young J. (IARC
Sc. Publication No. 143, Lyon, France).
2. Briggs N.D. and Katchy K.C. Pattern of primary gynaecological
malignancies as seen in a tertiary hospital situated in the Rivers
State of Nigeria. Int. J. Gynecol. Obstet. 1990; 31:157-161.
3. Kasule J. The pattern of gynaecological malignancy in Zimbabwe.
East Afr. Med. J. 1989; 66:393-399.
538 EAST AFRICAN MEDICAL JOURNAL October 2000
4. Rogo K.O, Omany J, Ojwang S.B. and Stendahl U. Carcinoma of
the cervix in the African setting. Int. J. Gynec. Obstet. 1990;
33:249-255.
5. Guisberg S.B. and Mulvihill M.N. Epidemiology . In: Clinics in
Obstetrics and Gynaecology - Endometrial Cancer. Ed. Creasman
W.T. ( W.B. Saunders Co. London). 1986; 13:665-672..
6. Mack T.M., Cozen W. and Quinn M.A. Epidemiology of cancer of
the endometrium, ovary, vulva and vagina. In: Gynecologic
Oncology, Second edition, Vol. 1, pages 31-54. Eds. Coppleson
M., Monaghan J.M., Morrow P.C., Tattersal M.H.N. Churchill-
Livingstone, New York; 1992.
7. Emembolu J.O. and Ekwempu C.C. Carcinoma of the cervix uteri
in Zaria: etiological factors. Int. J. Gynec. Obstet. 1988; 26:265-
269.
8. Armon P.J. and Missaleh W. Carcinoma of the cervix in Tanzania.
East Afr. Med. J. 1978; 55:534-537
9. Agyei W.K.A. and Hill R.B. Sexual behaviour, reproductive
health and contraceptive use among adolescents and young adults
in Ghana. (Paper presented at the Research Seminar to disseminate
some of the findings of the “Ghana Adolescent Fertility Survey”,
March 1997, Accra.)
10. Mati J.K.G. A review on adolescent health. J. Obstet. Gynaec. East
Cent. Afr. 1989; 8:19-23.
11. Gorgen R., Yansane M.L., Marx M. and Millimounou D. Sexual
behaviour and attitudes among unmarried youths in Guinea. Int.
Fam. Plan. Perspect. 1998; 24:65-71.
12. Makinwa-Adebusoye P. Sexual behaviour, reproductive knowledge
and contraceptive use among young urban Nigerians. Int. Fam.
Plan. Persp. 1992; 18:66-70.
13. Kasule J., Coulson R. and Akino V. Cancer of the cervix in
Zimbabwe - a prospective clinico-epidemiological study of 211
patients. J. Obstet. Gynaec. East Cent. Afr. 1989; 8:61-64.
14. Jennings O.G., Soeters R.P., Tiltman A.J., van Wijk A.L., Dehaeck
K., Block B. and Lombard C.J. The natural history of carcinoma
of the cervix in young women. S. Afr. Med. J. 1992, 82:351-354
15. Amiogbodun A.O. and Akanmu T.I. Clinicopathologic correlates
of disease stage in Nigerian cervical cancer patients. J. Obstet.
Gynaec. East Cent. Afr. 1992; 9:79-81.
16. Hay D.M. and Cole F.M. Primary invasive carcinoma of the vulva
in Jamaica. J. Obstet. Gynaec. Brit. Commwlth. 1969; 76:821-830.
17. Workshop Highlights: Alternatives for Cervical Cancer Screening
and Treatment in Low-Resource Settings (held 21st-22nd May
1997). JHPIEGO Corporation, Baltimore, USA, December 1997.
KENYA OBSTETRICAL AND
GYNAECOLOGICAL SOCIETY
26th Annual Scientific Conference
21st – 23rd February 2001
Theme:Safe Motherhood and its Challenges
Venue: Holiday Inn, Nairobi
For further details, contact: Secretary, Kenya Obstetrical and
Gynaecological Society, P.O. Box 19459, Nairobi, Kenya
